HRA Pharma to market menopause treatment in Europe
28 September 2009
Simon Varcoe
Please Login to read the full article.
28 September 2009
Simon Varcoe
simon.varcoe@informa.com
HRA Pharma is to market the Australian drug delivery company Acrux's transdermal estradiol spray in certain European countries.
The private French company will be responsible for obtaining marketing approval for the spray, which is intended to reduce symptoms of menopause, in France, Germany,...
Please Login to read the full article.
RELATED CONTENT
NEWS
- UK still tops European biotech pipeline league
- US Capitol Capsule: Supreme Court takes another stab at refining US patent law
- AZ's MedImmune sues Abbott over non-development and $50m payment deficit for RSV antibodies
- European positive opinion for Allergan's Botox for neurogenic bladder incontinence
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
